[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
…, GN Dalekos, N Gatselis, A Stefos… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
An open label trial of anakinra to prevent respiratory failure in COVID-19
…, N Gatselis, E Karakike, M Saridaki, G Loli, A Stefos… - Elife, 2021 - elifesciences.org
Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
[HTML][HTML] Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome
BACKGROUND: Spontaneous spondylodiscitis is an uncommon disease, which may result
in serious complications with potentially high morbidity and mortality. We conducted a …
in serious complications with potentially high morbidity and mortality. We conducted a …
[HTML][HTML] Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection
…, V Vittoros, IM Koutelidakis, A Pantazi, A Stefos… - BMC infectious …, 2018 - Springer
Background Development of sepsis is a process with significant variation among individuals.
The precise elements of this variation need to be defined. This study was designed to …
The precise elements of this variation need to be defined. This study was designed to …
Diabetes on sepsis outcomes in non-ICU patients: a cohort study and review of the literature
Aims We sought to determine whether primary outcomes differ between non-ICU septic
patients with and without type 2 diabetes (T2D). Methods This study utilized the Hellenic Sepsis …
patients with and without type 2 diabetes (T2D). Methods This study utilized the Hellenic Sepsis …
[HTML][HTML] Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)
…, V Korten, H Bilgin, GN Dalekos, A Stefos… - …, 2023 - thelancet.com
Background Data on risk factors for carbapenem-resistant Enterobacterales (CRE) with wider
applicability are needed to inform preventive measures and efficient design of randomised …
applicability are needed to inform preventive measures and efficient design of randomised …
Leptospirosis and pancytopenia: two case reports and review of the literature
A Stefos, SP Georgiadou, C Gioti, A Loukopoulos… - Journal of Infection, 2005 - Elsevier
Besides the classical manifestations, leptospirosis may rarely occur with erythroid hypoplasia
and/or pancytopenia. In this study, we reported two cases of leptospirosis presented with …
and/or pancytopenia. In this study, we reported two cases of leptospirosis presented with …
MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19
…, I Koulas, A Samakidou, A Nikolaidou, A Stefos… - Immunobiology, 2021 - Elsevier
The COVID-19 pandemic represents one of the greatest challenges in modern medicine.
The disease is characterized by a variable clinical phenotype, ranging from asymptomatic …
The disease is characterized by a variable clinical phenotype, ranging from asymptomatic …
[HTML][HTML] Soluble IL-2R levels at baseline predict the development of severe respiratory failure and mortality in COVID-19 patients
…, A Samakidou, A Vaiou, G Vatidis, K Antoniou, A Stefos… - Viruses, 2022 - mdpi.com
Risk stratification of coronavirus disease-19 (COVID-19) patients by simple markers is
critical to guide treatment. We studied the predictive value of soluble interleukin-2 receptor (sIL-2R…
critical to guide treatment. We studied the predictive value of soluble interleukin-2 receptor (sIL-2R…
[HTML][HTML] Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece
SP Georgiadou, A Stefos, G Spanakos… - International Journal of …, 2015 - Elsevier
Objectives Visceral leishmaniasis (VL) is re-emerging in endemic areas. The epidemiological,
clinical, laboratory, and treatment outcome characteristics in a large cohort of VL patients …
clinical, laboratory, and treatment outcome characteristics in a large cohort of VL patients …